Results 61 to 70 of about 2,263 (160)

Therapeutic tactics with violations of the menstrual cycle caused by ovulative dysfunction

Медицинский совет, 2018
Purpose: presentation of modern data on the pathogenesis of menstrual cycle disorders (NMCs) associated with ovulatory dysfunction, and the effectiveness of their treatment with medication.Basic provisions.
G. B. Dikke
doaj   +1 more source

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder

International Journal of Women's Health, 2009
Lesley L Breech, Paula K BravermanDivision of Adolescent Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USAAbstract: Premenstrual dysphoric ...
Lesley L Breech, Paula K Braverman
doaj  

Hormone withdrawal-associated symptoms with ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 µg/desogestrel 150 µg (21/7 regimen)

International Journal of Women's Health, 2015
Johannes Bitzer,1 Maria Jesusa Banal-Silao,2 Hans-Joachim Ahrendt,3 Jaime Restrepo,4 Marion Hardtke,5 Ulrike Wissinger-Graefenhahn,6 Dietmar Trummer7 1Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, Switzerland; 2University ...
Bitzer J, Banal-Silao MJ, Ahrendt HJ, Restrepo J, Hardtke M, Wissinger-Graefenhahn U, Trummer D   +6 more
doaj  

Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review

Clinical Interventions in Aging, 2008
Sebastián Carranza-LiraReproductive Medicine, UMAE Hospital de Ginecología y Obstetricia “Luis Castelazo Ayala” Instituto Mexicano del Seguro Social, MéxicoAbstract: During menopause vasomotor symptoms are one of the main
Sebastián Carranza-Lira
doaj  

Safety and tolerability of a combined oral contraceptive containing estetrol/drospirenone in real-life clinical practice: An open-label, prospective, multicenter, epidemiological, observational program "Estetiko"

Гинекология
Aim. To evaluate the safety and acceptability of a combined oral contraceptive (COC) containing estetrol 15 mg and drospirenone 3 mg when taken for 6 cycles in real clinical practice. Materials and methods. An open-label prospective multicenter (in 20
Natalia V. Aganezova, Rushania I. Gabidullina   +1 more
doaj   +1 more source

Drospirenone and PCOS [PDF]

Journal of Family Planning and Reproductive Health Care, 2005
openaire   +2 more sources

Drospirenone–Ethinyl Estradiol and Cyproterone Acetate in Moderate Severe Acne with Hyperandrogenism: A Randomized Double-Blind Trial

Indonesian Journal of Obstetrics and Gynecology
Background: Acne vulgaris is a health problem experienced by 85% of people in Indonesia. The highest prevalence is in women, who attempt to treat acne vulgaris. Unsuccessful acne vulgaris therapy is associated with hormonal influences, the stimulation of
Eka Rusdianto Gunardi, Irma Bernadette, Riyan Hari Kurniawan, Astri Noviani   +3 more
doaj   +1 more source

Personal selection of hormonal contraception [PDF]

Гинекология, 2017
Hormonal contraception is a highly effective means of protecting against unwanted pregnancy and has been widely used throughout the world for more than 50 years.
I V Kuznetsova
doaj  

Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception

Гинекология, 2018
Introduction. Androgen-dependent dermopathy, as well as premenstrual syndrome of varying severity in young women, can cause emotional depression, difficulties in social adaptation and even depressive disorders.
A.R.Khachaturian, E.V.Misharina, M.I.Yarmolinskaya   +2 more
doaj  

Drospirenone [PDF]

, 2020
openaire   +1 more source